Filter posts

#BIOCEO19: Navigating Payers’ Expectations for Value-Based Agreements

Value-based agreements are becoming increasingly important in the biopharmaceutical reimbursement space, particularly as new advanced …

Market Outlook—Leveraging Market Corrections for M&A or IPOs

After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year …

New BIO Report on Impact of Sarbanes-Oxley 404(b) on Emerging Biotech Innovators

BIO is out with a new report illustrating the negative impact of Sarbanes-Oxley 404(b) on …

#BIOCEO19 Kicks Off in NYC

Pharmaceutical innovation is not slowing down. Last year the FDA approved a total of 59 …

Pro-GMO Chocolate Brand Shares How GMOs Are Saving Some of World’s Most Cherished Foods

Just one week before Valentine’s Day, a unique brand of chocolate bars called Ethos Chocolate …

Health Care in Focus as President Trump Addresses the Nation

In his State of the Union address, President Trump described the need to rein in …